Data / Hiring / Massachusetts / Cerevel Therapeutics, LLC
Cerevel Therapeutics, LLC in Cambridge, MA: 7 certified H-1B cases, FY2023 to FY2026
Cerevel Therapeutics, LLC, Cambridge, MA, had 7 certified H-1B cases in Department of Labor disclosure data, decided from January 2, 2023 to July 19, 2024: 7 H-1B labor condition applications. Its most frequent role is Principal Analyst, Clinical Programming in Larenceville, NJ, at a median offered wage of $139,000 a year.
SpecStream is the live web data engine for teams and agents. It reads the Department of Labor's H-1B and PERM disclosure files and keeps each employer's filings by role, place and wage. Ask for your own cut (a role, a state, a list of companies) and new filings arrive in your sheet, CRM, Slack or agent.
- 83-1334174Employer ID (FEIN)
- Cambridge, MAAddress
- 7Certified cases
- 7Positions requested
- 0Denied or withdrawn
Certified cases by fiscal year
Fiscal years run from October 1 to September 30. The latest year covers decisions through July 19, 2024.
| Fiscal year | H-1B | PERM | Positions | Median offered wage |
|---|---|---|---|---|
| FY2023 | 4 | 0 | 4 | $159,500 |
| FY2024 | 3 | 0 | 3 | $130,000 |
Roles certified
Cases with the same job title, occupation code and worksite are grouped. Offered wage is the wage the employer filed; the range leaves out the lowest and highest 5% when a group has 20 cases or more. The prevailing wage is the one the employer filed against. A blank worksite means the file does not give one.
| Job title | Occupation | Worksite | Cases | Years | Median offered | Offered range | Median prevailing | Wage level | Program | Latest decision | Latest case number | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Principal Analyst, Clinical Programming | 19-1029 Bioinformatics Scientists | Larenceville, NJ | 1 | FY2024 | $140,000 | $140,000 to $163,000 | $84,053 | III | H-1B | June 11, 2024 | I-200-24156-070907 | dol.gov |
| Principal Analyst, Clinical Programming | 19-1029 Bioinformatics Scientists | Cambridge, MA | 1 | FY2023 | $139,000 | $139,000 to $164,000 | $106,413 | III | H-1B | March 24, 2023 | I-200-23076-858126 | dol.gov |
| Principal Scientist, Formulation Development | 19-2031 Chemists | Somerset, NJ | 1 | FY2024 | $130,000 | $130,000 to $166,000 | $115,648 | IV | H-1B | July 19, 2024 | I-200-24194-194467 | dol.gov |
| Principal Scientist, Formulation Development | 19-2031 Chemists | Cambridge, MA | 1 | FY2023 | $131,000 | $131,000 to $168,000 | $108,784 | III | H-1B | January 2, 2023 | I-200-22360-660397 | dol.gov |
| Research Scientist, Formulation Development | 19-2031 Chemists | Cambridge, MA | 1 | FY2024 | $120,119 | $120,119 to $138,000 | $120,119 | H-1B | May 1, 2024 | I-200-24116-923520 | dol.gov | |
| Senior Director, Medical Affairs | 11-9111 Medical and Health Services Managers | Cambridge, MA | 1 | FY2023 | $300,000 | $300,000 to $350,000 | $174,034 | IV | H-1B | May 2, 2023 | I-200-22181-325463 | dol.gov |
| Senior Manager, Clinical Pharmacology | 19-1042 Medical Scientists, Except Epidemiologists | Cambridge, MA | 1 | FY2023 | $180,000 | $180,000 to $191,113 | $143,686 | IV | H-1B | July 6, 2023 | I-200-23179-150366 | dol.gov |
Worksite states
| State | Cases |
|---|---|
| Massachusetts | 5 |
| New Jersey | 2 |
Also on SpecStream
- Every company hiring Chemists in Massachusetts
- Every company hiring Molecular and Cellular Biologists in New Jersey
- Every company hiring Molecular and Cellular Biologists in Massachusetts
Updated July 19, 2024. Read from US Department of Labor, Office of Foreign Labor Certification. Public domain (U.S. government work). A certified labor condition application (H-1B, H-1B1, E-3) or PERM labor certification is an employer filing the Department of Labor approved. It is not a count of people hired or visas issued. Wages are as the employer filed them, converted to a yearly figure at 2,080 hours; a wage whose unit is missing is left blank. The files show the first worksite of a case. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.